Related Experiment Video

Updated: Jun 2, 2026

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils
15:04

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils

Published on: September 28, 2019

Mitochondria, Amyloid β, and Alzheimer's Disease

Ryan D Readnower1, Andrew D Sauerbeck, Patrick G Sullivan

  • 1Spinal Cord & Brain Injury Research Center, University of Kentucky, Lexington, KY 40536, USA.

International Journal of Alzheimer'S Disease
|May 7, 2011
PubMed

Insights

Alzheimer's disease (AD) involves brain hypometabolism, linked to mitochondrial dysfunction. Amyloid-beta accumulation in mitochondria disrupts enzymes, increasing oxidative stress and contributing to AD's progression.

Area of Science:

  • Neuroscience
  • Mitochondrial Biology
  • Alzheimer's Disease Pathophysiology

Background:

  • Alzheimer's disease (AD) is characterized by brain hypometabolism.
  • Mitochondria are increasingly recognized as key players in AD neuropathology.
  • Amyloid-beta (Aβ) accumulation within mitochondria precedes extracellular deposition.

Purpose of the Study:

  • To elucidate the role of mitochondrial dysfunction in Alzheimer's disease pathogenesis.
  • To investigate the impact of amyloid-beta on mitochondrial enzymes and oxidative stress.

Main Methods:

  • Analysis of mitochondrial amyloid-beta accumulation.
  • Assessment of amyloid-beta's direct and indirect effects on mitochondrial enzyme activity.
  • Evaluation of oxidative stress markers in relation to mitochondrial function.
  • Investigation of amyloid-beta interaction with cyclophilin D and the mitochondrial permeability transition pore.

Main Results:

  • Mitochondrial amyloid-beta accumulation is an early event in Alzheimer's disease.
  • Amyloid-beta directly inhibits mitochondrial enzymes, exacerbating oxidative stress.
  • This inhibition perpetuates a hypometabolic state characteristic of Alzheimer's disease.
  • Amyloid-beta interaction with cyclophilin D may contribute to neuronal cell death.

Conclusions:

  • Mitochondria play a critical role in the pathophysiology of Alzheimer's disease.
  • Mitochondrial dysfunction, driven by amyloid-beta, is central to Alzheimer's disease progression.
  • Targeting mitochondrial pathways represents a potential therapeutic strategy for Alzheimer's disease.

More Related Videos

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models08:48

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models

Published on: June 30, 2023

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP07:55

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP

Published on: October 17, 2015

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...